Sort by
Previous Page Page 2 of 2 Next Page
  1. Methodology

    Publishing descriptions of non-public clinical datasets: proposed guidance for researchers, repositories, editors and funding organisations

    Sharing of experimental clinical research data usually happens between individuals or research groups rather than via public repositories, in part due to the need to protect research participant privacy. This ...

    Iain Hrynaszkiewicz, Varsha Khodiyar, Andrew L. Hufton and Susanna-Assunta Sansone

    Research Integrity and Peer Review 2016 1:6

    Published on: 22 June 2016

  2. Methodology

    Updating standards for reporting diagnostic accuracy: the development of STARD 2015

    Although the number of reporting guidelines has grown rapidly, few have gone through an updating process. The STARD statement (Standards for Reporting Diagnostic Accuracy), published in 2003 to help improve th...

    Daniël A. Korevaar, Jérémie F. Cohen, Johannes B. Reitsma, David E. Bruns, Constantine A. Gatsonis, Paul P. Glasziou, Les Irwig, David Moher, Henrica C. W. de Vet, Douglas G. Altman, Lotty Hooft and Patrick M. M. Bossuyt

    Research Integrity and Peer Review 2016 1:7

    Published on: 7 June 2016

  3. Review

    Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use

    Sex and gender differences are often overlooked in research design, study implementation and scientific reporting, as well as in general science communication. This oversight limits the generalizability of res...

    Shirin Heidari, Thomas F. Babor, Paola De Castro, Sera Tort and Mirjam Curno

    Research Integrity and Peer Review 2016 1:2

    Published on: 3 May 2016

    The Erratum to this article has been published in Research Integrity and Peer Review 2016 1:8

  4. Methodology

    Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency

    Interventional clinical studies conducted in the regulated drug research environment are reported using International Council for Harmonisation (ICH) regulatory guidance documents: ICH E3 on the structure and ...

    Samina Hamilton, Aaron B. Bernstein, Graham Blakey, Vivien Fagan, Tracy Farrow, Debbie Jordan, Walther Seiler, Anna Shannon and Art Gertel

    Research Integrity and Peer Review 2016 1:4

    Published on: 3 May 2016

  5. Review

    Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency

    Conflicts of interest held by researchers remain a focus of attention in clinical research. Biases related to these relationships have the potential to directly impact the quality of healthcare by influencing ...

    Adam G. Dunn, Enrico Coiera, Kenneth D. Mandl and Florence T. Bourgeois

    Research Integrity and Peer Review 2016 1:1

    Published on: 3 May 2016

  6. Research

    Propagation of errors in citation networks: a study involving the entire citation network of a widely cited paper published in, and later retracted from, the journal Nature

    In about one in 10,000 cases, a published article is retracted. This very often means that the results it reports are flawed. Several authors have voiced concerns about the presence of retracted research in th...

    Paul E. van der Vet and Harm Nijveen

    Research Integrity and Peer Review 2016 1:3

    Published on: 3 May 2016

  7. Editorial

    A new forum for research on research integrity and peer review

    This editorial explains why we are launching Research Integrity and Peer Review, a new open-access journal that will provide a home to research on ethics, reporting, and evaluation of research. We discuss how the...

    Stephanie L. Harriman, Maria K. Kowalczuk, Iveta Simera and Elizabeth Wager

    Research Integrity and Peer Review 2016 1:5

    Published on: 3 May 2016

Previous Page Page 2 of 2 Next Page